GAMMA Investing’s GoHealth GOCO Stock Holding History

GAMMA Investing’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-54	Closed	-$663	–	3827
2025 Q1	$663	Buy	54 +29	+116%	+$443	﹤0.01%	3635
2024 Q4	$335	Buy	+25	New	+$284	﹤0.01%	3649

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

GAMMA Investing's GOCO Position: Q2 2025 in Review

GAMMA Investing sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 54 shares — an estimated $663 sold.

GAMMA Investing first reported a position in GOCO in Q4 2024 and held it in 2 quarters. The position peaked at $663 in Q1 2025. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

GAMMA Investing reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
GAMMA Investing sold 54 GoHealth shares in Q2 2025, an estimated $663.
GAMMA Investing first reported a position in GoHealth in Q4 2024 and held it in 2 quarters.
GAMMA Investing's GoHealth position peaked at $663 in Q1 2025.
55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.